By: Paul Singh, Kristen Dowd, Anthony DeFino
ORLANDO — Implantation of the iDose TR in combination with cataract surgery yielded robust IOP reduction while maintaining a positive safety
San Francisco, United States (Local)


Not enough data
Paul Singh's coverage primarily focuses on ophthalmology, with a specific emphasis on eye conditions such as dry eye and cataract surgery. Given this focus, he is likely to be receptive to pitches related to advancements in ophthalmic technology, new treatments for eye conditions, and expert insights from professionals in the field.
Additionally, topics related to liver disease treatment options beyond transplantation and transgender rights seem to feature sporadically in his articles. If you have expertise or access to experts in these areas who can provide unique insights or commentary related to evolving stories or events within these fields, Paul may find them relevant for potential coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .